Extracorporeal membrane oxygenation therapy in neonates with septic shock.
Neonatal septic shock has significant morbidity and mortality with current therapeutic measures. At Children's National Medical Center, from June 1984 to October 1986, 10 of 100 patients treated with venoarterial extracorporeal membrane oxygenation (ECMO) had a documented diagnosis of septic shock. All of these infants fulfilled criteria consistent with 80% mortality using conventional intensive medical management. However, the survival rate for the septic neonates in this study was 100%. Compared with other groups of infants treated with ECMO, these septic neonates required significantly more ventilatory support after ECMO and had a higher incidence of chronic lung disease (30% v 12%). The septic neonates were also at higher risk for intracranial hemorrhage than the other infants treated with ECMO (40% v 26%). The necessity for prolonged intubation after ECMO for patients with septic shock suggests that this condition may be associated with additional structural damage not seen with meconium aspiration syndrome or respiratory distress syndrome. Nevertheless, for neonatal patients with septic shock unresponsive to conventional medical management, ECMO must be considered a viable alternative treatment.
McCune
S
S
Department of Child Health and Development and Surgery, George Washington University, Washington, DC.
Short
B L
BL
Miller
M K
MK
Lotze
A
A
Anderson
K D
KD
D002543:Cerebral Hemorrhage / Q000209:etiology; D002908:Chronic Disease; D015199:Extracorporeal Membrane Oxygenation / Q000009:adverse effects / Q000401:mortality; D006801:Humans; D007231:Infant, Newborn; D008171:Lung Diseases / Q000209:etiology; D010043:Outcome and Process Assessment, Health Care; D012189:Retrospective Studies; D012772:Shock, Septic / Q000401:mortality / Q000628:therapy*; D015996:Survival Rate